- Home
- MCY vs PRCT Comparison
MCY vs PRCT Comparison
Compare MCY & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCY
- PRCT
- Stock Information
- Founded
- MCY 1961
- PRCT 2009
- Country
- MCY United States
- PRCT United States
- Employees
- MCY N/A
- PRCT N/A
- Industry
- MCY Property-Casualty Insurers
- PRCT Medical Specialities
- Sector
- MCY Finance
- PRCT Health Care
- Exchange
- MCY Nasdaq
- PRCT Nasdaq
- Market Cap
- MCY 3.1B
- PRCT 3.2B
- IPO Year
- MCY N/A
- PRCT 2021
- Fundamental
- Price
- MCY $65.74
- PRCT $58.18
- Analyst Decision
- MCY Strong Buy
- PRCT Strong Buy
- Analyst Count
- MCY 1
- PRCT 7
- Target Price
- MCY $80.00
- PRCT $90.00
- AVG Volume (30 Days)
- MCY 368.2K
- PRCT 850.8K
- Earning Date
- MCY 05-06-2025
- PRCT 04-24-2025
- Dividend Yield
- MCY 1.97%
- PRCT N/A
- EPS Growth
- MCY 32.82
- PRCT N/A
- EPS
- MCY 5.16
- PRCT N/A
- Revenue
- MCY $5,595,427,000.00
- PRCT $249,121,000.00
- Revenue This Year
- MCY $7.13
- PRCT $47.40
- Revenue Next Year
- MCY $7.60
- PRCT $31.81
- P/E Ratio
- MCY $12.50
- PRCT N/A
- Revenue Growth
- MCY 16.64
- PRCT 59.36
- 52 Week Low
- MCY $44.19
- PRCT $47.04
- 52 Week High
- MCY $80.72
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- MCY 67.06
- PRCT 50.98
- Support Level
- MCY $59.01
- PRCT $54.72
- Resistance Level
- MCY $61.94
- PRCT $59.19
- Average True Range (ATR)
- MCY 1.31
- PRCT 2.57
- MACD
- MCY 0.19
- PRCT 0.06
- Stochastic Oscillator
- MCY 88.29
- PRCT 61.64
About MCY Mercury General Corporation
Mercury General Corp is an insurance holding company. It is engaged in writing personal automobile insurance and provides related property and casualty insurance products. The Company offers the following types of automobile coverage: collision, property damage, bodily injury ("BI"), comprehensive, personal injury protection ("PIP"), underinsured and uninsured motorist, and other hazards. The Company offers the following types of homeowners coverage: dwelling, liability, personal property, and other coverages.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.